Project: Next Generation Vaccines for Multi-Resistant Bacteria
| Acronym | CDIFFVAC (Reference Number: 114317) |
| Duration | 01/09/2020 - 01/03/2023 |
| Project Topic | Do: Complete TRL4 of the vaccine candidate pb-cd01 targeting Clostridium difficile infection (CDI) to prepare it for TRL5 (followed by a clinical trial authorization (CTA) application and clinical trials) Deliver: A vaccine to protect from or treat Clostridium difficile infection |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 13 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Cellvax SAS | Partner | France |
| 2 | LiteVax BV | Partner | Netherlands |
| 3 | Proxi Biotech ApS | Coordinator | Denmark |